Commentary: combination chemotherapy of nonseminomatous testicular cancer

Iron addiction: a novel therapeutic target in ovarian cancer.

Oncogene·2017

Effects of Anti-repulsive Guidance Molecule C (RGMc/Hemojuvelin) Antibody on Hepcidin and Iron in Mouse Liver and Tumor Xenografts.

Clinical & experimental pharmacology·2017

Heat localization for targeted tumor treatment with nanoscale near-infrared radiation absorbers.

Physics in medicine and biology·2012

The core control system of intracellular iron homeostasis: a mathematical model.

Journal of theoretical biology·2012

Curcumin: from ancient medicine to current clinical trials.

Cellular and molecular life sciences : CMLS·2008

p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator.

Carcinogenesis·2001

Continuous infusion of granulocyte colony-stimulating factor is associated with an advantage in neutrophil recovery in pediatric oncologic disorders.

Cancer chemotherapy and pharmacology·2026

Population pharmacokinetic analysis of pirtobrutinib, a non-covalent BTK inhibitor, in patients with hematological malignancies from the Phase 1/2 BRUIN study.

Cancer chemotherapy and pharmacology·2026

Association of androgen deprivation therapy and acute kidney injury in patients with prostate cancer: a systematic review and meta-analysis of 72,980 patients.

Cancer chemotherapy and pharmacology·2026

Crossing the toxicity threshold: a repeated landmark analysis of early toxicities and treatment modification during first-line CDK4/6 inhibitor therapy.

Cancer chemotherapy and pharmacology·2026

CNS distribution and preclinical activity of the PI3K/AKT inhibitors inavolisib and ipatasertib in pediatric-type diffuse high-grade gliomas.

Cancer chemotherapy and pharmacology·2026

Outcomes of locally produced donor-derived anti-CD19 chimeric antigen receptor T-cells in relapsed or refractory B-cell acute lymphoblastic leukemia patients.

Cancer chemotherapy and pharmacology·2026

Effects of Ciprofol- versus Remimazolam-Based Total Intravenous Anesthesia on Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Randomized Controlled Trial.

Drug design, development and therapy·2026

A berberine-functionalized green silver nanoplatform for combined chemo-photodynamic therapy against breast cancer cells.

Nanoscale advances·2026

Preclinical mechanistic study of rotundic acid against cyclophosphamide-induced nephrotoxicity in Swiss albino mice through modulation of oxidative stress, inflammation, apoptosis, and fibrosis via NF-κB/Caspase-3/TGF-β1 Pathways.

Biochemical and biophysical research communications·2026

Biological effects of N-acetylcysteine, calcium hydroxide, chlorhexidine and their combinations as intracanal medications: cytotoxicity, genotoxicity and cytokine modulation.

BDJ open·2026

Clinical Determinants Influencing First-line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma in Japan.

Anticancer research·2026

Comparing the real-world effectiveness of oral corticosteroids and antifungals for the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.

Chest·2026

Related Experiment Videos

Commentary: combination chemotherapy of nonseminomatous testicular cancer

Related Concept Videos

Iron addiction: a novel therapeutic target in ovarian cancer.

Effects of Anti-repulsive Guidance Molecule C (RGMc/Hemojuvelin) Antibody on Hepcidin and Iron in Mouse Liver and Tumor Xenografts.

Heat localization for targeted tumor treatment with nanoscale near-infrared radiation absorbers.

The core control system of intracellular iron homeostasis: a mathematical model.

Curcumin: from ancient medicine to current clinical trials.

p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator.

Continuous infusion of granulocyte colony-stimulating factor is associated with an advantage in neutrophil recovery in pediatric oncologic disorders.

Population pharmacokinetic analysis of pirtobrutinib, a non-covalent BTK inhibitor, in patients with hematological malignancies from the Phase 1/2 BRUIN study.

Association of androgen deprivation therapy and acute kidney injury in patients with prostate cancer: a systematic review and meta-analysis of 72,980 patients.

Crossing the toxicity threshold: a repeated landmark analysis of early toxicities and treatment modification during first-line CDK4/6 inhibitor therapy.

CNS distribution and preclinical activity of the PI3K/AKT inhibitors inavolisib and ipatasertib in pediatric-type diffuse high-grade gliomas.

Outcomes of locally produced donor-derived anti-CD19 chimeric antigen receptor T-cells in relapsed or refractory B-cell acute lymphoblastic leukemia patients.

Effects of Ciprofol- versus Remimazolam-Based Total Intravenous Anesthesia on Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Randomized Controlled Trial.

A berberine-functionalized green silver nanoplatform for combined chemo-photodynamic therapy against breast cancer cells.

Preclinical mechanistic study of rotundic acid against cyclophosphamide-induced nephrotoxicity in Swiss albino mice through modulation of oxidative stress, inflammation, apoptosis, and fibrosis via NF-κB/Caspase-3/TGF-β1 Pathways.

Biological effects of N-acetylcysteine, calcium hydroxide, chlorhexidine and their combinations as intracanal medications: cytotoxicity, genotoxicity and cytokine modulation.

Clinical Determinants Influencing First-line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma in Japan.

Comparing the real-world effectiveness of oral corticosteroids and antifungals for the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.

Related Experiment Videos

Commentary: combination chemotherapy of nonseminomatous testicular cancer

Related Concept Videos

Related Articles